Stay updated on Elacestrant in ER+ Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a publication citation for the EMERALD trial (JCO 2022). Removed an Erratum entry related to that publication.
    Difference
    0.0%
    Check dated 2026-03-08T03:35:23.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.1 to v3.4.2. No substantive changes to the study details or page layout are observed.
    Difference
    0.0%
    Check dated 2026-02-14T13:44:55.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Publication reference updated: EMERALD JCO 2022 article added with Erratum and older version removed. Page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-07T07:57:23.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle and new metadata fields such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', plus a 'No FEAR Act Data' item and a 'Revision: v3.4.0' note.
    Difference
    0.1%
    Check dated 2026-01-24T07:41:13.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page reflects Revision: v3.3.4 and removes Revision: v3.3.3, indicating a minor document revision. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T06:38:41.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Expanded the Locations section to include a comprehensive list of participating sites across numerous countries and U.S. states. This provides clearer visibility into where the study is conducted.
    Difference
    3%
    Check dated 2025-12-19T19:19:56.000Z thumbnail image

Stay in the know with updates to Elacestrant in ER+ Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.